ABT - Abbott Laboratories

NYSE - Nasdaq Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income2,368,000477,0001,400,0004,423,000
Operating Activities, Cash Flows Provided By or Used In
Depreciation3,278,0003,019,0001,351,0001,427,000
Adjustments To Net Income802,000154,0001,800,000-2,728,000
Changes In Accounts Receivables-190,000-207,000-177,000-171,000
Changes In Liabilities747,000615,000-652,000-742,000
Changes In Inventories-514,000249,000-98,000-257,000
Changes In Other Operating Activities23,000109,000113,00057,000
Total Cash Flow From Operating Activities6,300,0005,570,0003,203,0002,966,000
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditure-1,394,000-1,135,000-1,121,000-1,110,000
Investments-58,000-81,000886,000-821,000
Other Cash flows from Investing Activities48,0002,739,00042,0002,342,000
Total Cash Flows From Investing Activities-1,356,000-9,618,000-248,000406,000
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid-1,974,000-1,849,000-1,539,000-1,443,000
Sale Purchase of Stock----
Net Borrowings-8,450,000-2,942,00013,155,0001,147,000
Other Cash Flows from Financing Activities--13,000-195,000-17,000
Total Cash Flows From Financing Activities-10,391,000-5,281,00011,147,000-2,236,000
Effect Of Exchange Rate Changes-116,000116,000-483,000-198,000
Change In Cash and Cash Equivalents-5,563,000-9,213,00013,619,000938,000